FDA paused trials for experimental drugs more often in recent years
[ad_1]
Jim O'Neill, managing director of the investment firm Mithril Capital, was deputy secretary of HHS. (Online News 72h Photo/Andrew Harnik, File) Andrew Harnik FDA paused trials for experimental drugs more often in recent years Abigail Adcox January 10, 02:40 PM January 10, 02:40 PM Video Embed T he Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years,...